ICU Monitoring Beyond Vitals: Advanced Hemodynamic and Metabolic Assessment in Critical Care

Dr Neeraj Manikath , claude.ai

Abstract

Background: Traditional vital signs provide limited insight into tissue perfusion and cellular metabolism in critically ill patients. Advanced monitoring parameters including lactate, central venous oxygen saturation (ScvO₂), point-of-care ultrasound (POCUS), and microcirculatory assessment offer deeper physiological understanding and guide targeted therapeutic interventions.

Objective: To provide a comprehensive review of advanced ICU monitoring techniques beyond conventional vitals, with practical implementation strategies and clinical pearls for critical care practitioners.

Methods: Systematic review of current literature on advanced hemodynamic monitoring, metabolic markers, and microcirculatory assessment in critical care settings.

Results: Integration of lactate monitoring, ScvO₂ assessment, POCUS evaluation, and microcirculatory parameters significantly enhances diagnostic accuracy, therapeutic guidance, and prognostic assessment in critically ill patients.

Conclusions: Advanced monitoring beyond vital signs is essential for optimal critical care management, requiring systematic implementation and continuous education for healthcare providers.

Keywords: Critical care monitoring, lactate, central venous oxygen saturation, point-of-care ultrasound, microcirculation, hemodynamic assessment

Introduction

The paradigm of intensive care monitoring has evolved significantly beyond the traditional assessment of heart rate, blood pressure, respiratory rate, and oxygen saturation. While these fundamental parameters remain important, they often fail to capture the complex pathophysiology underlying critical illness, particularly at the cellular and microcirculatory level¹. Modern critical care demands a more sophisticated approach that integrates metabolic markers, advanced hemodynamic parameters, and real-time imaging to guide therapeutic decisions and improve patient outcomes².

This comprehensive review examines four key areas of advanced ICU monitoring: lactate metabolism and clearance, central venous oxygen saturation (ScvO₂), point-of-care ultrasound (POCUS), and microcirculatory assessment. Each modality provides unique insights into different aspects of cellular metabolism, oxygen delivery and utilization, cardiac function, and tissue perfusion³.

Lactate: The Metabolic Mirror

Pathophysiology and Clinical Significance

Lactate has emerged as one of the most important biomarkers in critical care, serving as a metabolic mirror reflecting cellular oxygen debt and metabolic stress⁴. Traditionally viewed solely as a marker of tissue hypoxia through anaerobic metabolism, our understanding of lactate has evolved to recognize its role as both a metabolic substrate and a stress marker⁵.

Normal lactate levels range from 0.5-1.5 mmol/L, with values >2 mmol/L considered elevated and >4 mmol/L indicating severe metabolic stress⁶. Lactate elevation occurs through multiple mechanisms:

Type A (Hypoxic): Tissue hypoperfusion leading to anaerobic glycolysis
Type B (Non-hypoxic): Metabolic disorders, medications, malignancy, or stress response⁷

Clinical Applications and Monitoring Strategies

Sepsis and Shock Management

The Surviving Sepsis Campaign guidelines emphasize lactate as a key resuscitation endpoint, with initial levels >2 mmol/L triggering aggressive fluid resuscitation and vasopressor therapy⁸. The concept of lactate clearance has gained prominence, with studies demonstrating that patients achieving >10% clearance within 2 hours and >20% within 6 hours have significantly improved outcomes⁹.

Clinical Pearl: Lactate clearance is more predictive of outcome than absolute lactate values. A patient with an initial lactate of 6 mmol/L that decreases to 4 mmol/L (33% clearance) has a better prognosis than one with an initial lactate of 3 mmol/L that increases to 4 mmol/L.

Cardiac Surgery and Post-Operative Monitoring

In cardiac surgery patients, lactate levels >3 mmol/L at ICU admission are associated with increased mortality and prolonged ICU stay¹⁰. Serial lactate measurements help guide post-operative management and identify complications early.

Hack: In post-cardiac surgery patients, combine lactate trends with mixed venous oxygen saturation. Rising lactate with falling SvO₂ suggests inadequate cardiac output, while rising lactate with normal/high SvO₂ may indicate sepsis or liver dysfunction.

Advanced Lactate Concepts

Lactate-to-Pyruvate Ratio

The lactate-to-pyruvate (L/P) ratio provides insight into cellular redox state and mitochondrial function. Normal L/P ratio is <10, with ratios >20 indicating significant cellular dysfunction¹¹.

Point-of-Care Lactate Testing

Modern handheld lactate analyzers provide results within 60 seconds using minimal blood volumes (0.3-1.5 μL). This rapid turnaround enables real-time clinical decision-making¹².

Clinical Pearl: When using point-of-care lactate devices, ensure proper calibration and be aware that extreme hematocrit values (<20% or >60%) may affect accuracy.

Limitations and Confounders

Several factors can influence lactate interpretation:

Liver dysfunction (reduced clearance)
Medications (metformin, salbutamol, adrenaline)
Malignancy and chemotherapy
Seizures and excessive muscular activity
Sampling technique and storage conditions¹³

Oyster: Don't chase lactate levels in patients with known liver cirrhosis or those on metformin therapy. Focus on trends rather than absolute values and consider alternative markers of perfusion.

Central Venous Oxygen Saturation (ScvO₂): The Oxygen Balance Indicator

Physiological Basis

Central venous oxygen saturation reflects the balance between oxygen delivery (DO₂) and oxygen consumption (VO₂) at the tissue level¹⁴. Normal ScvO₂ ranges from 65-75%, representing the oxygen saturation of blood returning from the systemic circulation to the right ventricle.

The relationship can be expressed by the Fick equation: ScvO₂ = SaO₂ - (VO₂/CO × Hb × 1.34)

Where:

SaO₂ = arterial oxygen saturation
VO₂ = oxygen consumption
CO = cardiac output
Hb = hemoglobin concentration¹⁵

Clinical Applications

Early Goal-Directed Therapy (EGDT)

The Rivers trial popularized ScvO₂ monitoring as a resuscitation endpoint, targeting ScvO₂ >70% in septic shock¹⁶. While subsequent trials questioned the benefit of EGDT protocols, ScvO₂ remains a valuable monitoring tool when interpreted in clinical context¹⁷.

Cardiac Surgery and High-Risk Procedures

Perioperative ScvO₂ monitoring helps optimize oxygen delivery and identifies patients at risk for complications. Values <60% are associated with increased morbidity and mortality¹⁸.

Clinical Pearl: ScvO₂ trends are more valuable than single measurements. A declining ScvO₂ despite stable vital signs may indicate developing shock before traditional parameters change.

Technical Considerations

Sampling Location

True central venous sampling requires blood from the superior or inferior vena cava. Subclavian or internal jugular catheters positioned in the superior vena cava provide more reliable measurements than femoral catheters¹⁹.

Continuous vs. Intermittent Monitoring

Fiber-optic catheters enable continuous ScvO₂ monitoring but require frequent calibration and are more expensive. Intermittent blood gas sampling every 4-6 hours is often sufficient for clinical decision-making²⁰.

Interpretation Challenges

Low ScvO₂ (<65%)

Inadequate oxygen delivery (low cardiac output, anemia, hypoxemia)
Increased oxygen consumption (fever, shivering, agitation)
Impaired oxygen extraction

High ScvO₂ (>80%)

Sepsis with distributive shock
Cyanide poisoning or mitochondrial dysfunction
Arteriovenous shunting
Brain death²¹

Oyster: A normal ScvO₂ doesn't guarantee adequate tissue perfusion. In sepsis, impaired oxygen utilization at the cellular level may result in normal or elevated ScvO₂ despite ongoing tissue hypoxia.

Hack: Use the ScvO₂-lactate combination for better interpretation. Low ScvO₂ + high lactate suggests inadequate oxygen delivery, while high ScvO₂ + high lactate suggests impaired oxygen utilization (typical of sepsis).

Point-of-Care Ultrasound (POCUS): The Window to Physiology

Evolution and Impact

POCUS has revolutionized bedside assessment in critical care, providing real-time visualization of cardiac function, volume status, and organ pathology²². The integration of ultrasound into routine ICU care has improved diagnostic accuracy and reduced time to appropriate therapy²³.

Cardiovascular POCUS

Focused Echocardiography

The focused intensive care echocardiography (FICE) protocol provides rapid assessment of:

Left ventricular function and contractility
Right heart strain and pulmonary hypertension
Volume responsiveness
Pericardial pathology²⁴

Clinical Pearl: The "5-view" cardiac POCUS examination (parasternal long axis, parasternal short axis, apical 4-chamber, subcostal 4-chamber, and IVC view) can be completed in <5 minutes and provides essential hemodynamic information.

Volume Status Assessment

Inferior vena cava (IVC) assessment has become the cornerstone of volume status evaluation. IVC diameter and collapsibility index correlate with central venous pressure and fluid responsiveness:

IVC <2.1 cm with >50% collapsibility suggests CVP 0-5 mmHg
IVC >2.1 cm with <50% collapsibility suggests CVP 10-20 mmHg²⁵

Hack: In mechanically ventilated patients, measure IVC distensibility (expansion with positive pressure) rather than collapsibility. >15% distensibility suggests fluid responsiveness.

Pulmonary POCUS

Lung Ultrasound

Lung ultrasound has emerged as a powerful tool for diagnosing respiratory pathology at the bedside:

A-lines: Normal aerated lung
B-lines: Interstitial syndrome (pulmonary edema, ARDS)
Consolidation: Pneumonia, atelectasis
Pneumothorax: Absence of lung sliding²⁶

The BLUE protocol (Bedside Lung Ultrasound in Emergency) provides a systematic approach to respiratory failure diagnosis with >95% accuracy²⁷.

Clinical Pearl: Count B-lines in each intercostal space. >3 B-lines per space indicates interstitial syndrome. >5 B-lines suggest moderate to severe pulmonary edema.

Shock Evaluation

FALLS Protocol

The Fluid Administration Limited by Lung Sonography (FALLS) protocol integrates lung ultrasound with hemodynamic assessment:

Initial lung ultrasound assessment
Fluid challenge if no B-lines present
Reassess lung ultrasound post-fluid challenge
Stop fluids if B-lines develop²⁸

Hack: Use the "RUSH" (Rapid Ultrasound in Shock) protocol for systematic shock evaluation: Heart (function, tamponade), IVC (volume), Aorta (aneurysm), and Lungs (edema, pneumothorax).

Advanced POCUS Applications

Optic Nerve Sheath Diameter (ONSD)

ONSD measurement provides a non-invasive estimate of intracranial pressure. ONSD >5.0-5.7 mm suggests elevated ICP >20 mmHg²⁹.

Gastric Ultrasound

Assessment of gastric contents helps guide aspiration risk and feeding protocols in critically ill patients³⁰.

Quality Assurance and Training

Competency in POCUS requires structured training with minimum examination requirements:

Basic cardiac: 50 supervised studies
Advanced cardiac: 150 supervised studies
Lung ultrasound: 25 supervised studies³¹

Oyster: Remember that POCUS is operator-dependent. Ensure adequate training and maintain skills through regular practice. When in doubt, obtain formal echocardiography or imaging studies.

Microcirculatory Assessment: The Cellular Perspective

Pathophysiology of Microcirculatory Dysfunction

The microcirculation, comprising vessels <20 μm in diameter, represents the functional unit of oxygen and nutrient delivery to tissues³². Microcirculatory dysfunction occurs early in shock states and may persist despite correction of macrocirculatory parameters, contributing to organ failure and poor outcomes³³.

Assessment Techniques

Sublingual Videomicroscopy

Direct visualization of sublingual microcirculation using incident dark-field (IDF) or sidestream dark-field (SDF) imaging provides real-time assessment of:

Microvascular density
Proportion of perfused capillaries
Microvascular flow index
Heterogeneity index³⁴

Clinical Pearl: The sublingual area correlates well with visceral organ perfusion and is easily accessible for repeated measurements.

Near-Infrared Spectroscopy (NIRS)

NIRS provides continuous, non-invasive monitoring of tissue oxygen saturation (StO₂) and can assess microcirculatory function through vascular occlusion tests³⁵.

The vascular occlusion test (VOT) involves:

Baseline StO₂ measurement
Arterial occlusion until StO₂ decreases to 40%
Release and measurement of recovery parameters:
- Desaturation rate (reflects oxygen consumption)
- Resaturation rate (reflects microcirculatory reserve)³⁶

Skin Perfusion Assessment

Peripheral perfusion can be assessed through:

Capillary refill time (normal <3 seconds)
Skin temperature gradient (core-to-toe temperature difference >7°C suggests poor perfusion)
Peripheral perfusion index from pulse oximetry³⁷

Clinical Applications

Sepsis and Septic Shock

Microcirculatory dysfunction is a hallmark of sepsis, with impaired capillary density and flow despite adequate macrocirculatory resuscitation³⁸. Persistence of microcirculatory alterations predicts organ failure and mortality³⁹.

Clinical Pearl: In septic patients with restored blood pressure and cardiac output but persistent organ dysfunction, consider microcirculatory-targeted therapies such as vitamin C, thiamine, and hydrocortisone.

Hemorrhagic Shock

During hemorrhagic shock, microcirculatory assessment helps guide resuscitation beyond traditional endpoints. Persistent microcirculatory dysfunction despite hemodynamic stabilization indicates ongoing tissue hypoperfusion⁴⁰.

Post-Cardiac Surgery

Microcirculatory monitoring in cardiac surgery patients helps identify those at risk for complications and guides perioperative optimization⁴¹.

Emerging Technologies

Laser Speckle Contrast Imaging (LSCI)

LSCI provides real-time, full-field imaging of tissue perfusion without contrast agents. This technique shows promise for continuous microcirculatory monitoring⁴².

Photoplethysmography

Advanced photoplethysmography techniques can assess peripheral perfusion and autonomic function, providing insights into microcirculatory status⁴³.

Therapeutic Implications

Understanding microcirculatory dysfunction has led to targeted therapeutic approaches:

Nitroglycerin: Improves sublingual microcirculatory flow
Dobutamine: Enhances microcirculatory density in sepsis
Vasopressin: May improve microcirculatory flow in distributive shock
Hydrocortisone: Restores capillary density in septic shock⁴⁴

Hack: Use a systematic approach to microcirculatory assessment: Start with simple bedside techniques (capillary refill, skin temperature gradient) before progressing to advanced monitoring if available.

Oyster: Don't assume normal macrocirculatory parameters guarantee adequate microcirculatory function. In patients with persistent organ dysfunction despite hemodynamic optimization, consider microcirculatory-directed interventions.

Integration and Clinical Decision-Making

Multimodal Monitoring Approach

The optimal approach to advanced ICU monitoring involves integration of multiple parameters to create a comprehensive physiological picture⁴⁵. No single parameter provides complete information about the complex pathophysiology of critical illness.

The LACTATE-SCVO2-ECHO-MICRO Framework

A practical approach to integrate these monitoring modalities:

LACTATE: Initial assessment and trend monitoring
ScvO₂: Oxygen delivery-consumption balance
ECHO (POCUS): Cardiac function and volume status
MICRO: Microcirculatory assessment

Clinical Pearl: Use complementary information from different modalities. For example, rising lactate + falling ScvO₂ + reduced cardiac output on POCUS suggests cardiogenic shock, while rising lactate + normal/high ScvO₂ + hyperdynamic circulation suggests distributive shock.

Resuscitation Bundles and Protocols

Enhanced Sepsis Resuscitation

Modern sepsis resuscitation incorporates advanced monitoring:

Hour 0: Lactate, blood cultures, antibiotics
Hour 1: Fluid bolus (30 mL/kg), POCUS assessment
Hour 3: Lactate clearance, ScvO₂, microcirculatory assessment
Hour 6: Reassessment and optimization⁴⁶

Post-Operative Monitoring Protocol

For high-risk surgical patients:

Continuous ScvO₂ monitoring for first 24 hours
Serial lactate measurements (0, 6, 12, 24 hours)
POCUS assessment pre-operatively and post-operatively
Microcirculatory assessment if available⁴⁷

Technology Integration and EMR Implementation

Automated Data Collection

Modern ICU monitoring systems can integrate advanced parameters into electronic medical records (EMR), enabling:

Automated alerting for abnormal values
Trend analysis and visualization
Quality metrics and outcome tracking⁴⁸

Decision Support Systems

Clinical decision support systems incorporating advanced monitoring parameters can guide therapeutic interventions and improve adherence to evidence-based protocols⁴⁹.

Hack: Set up automated alerts in your EMR system: Lactate >4 mmol/L, lactate clearance <10% at 2 hours, ScvO₂ <65% or >80%, and combine with POCUS findings for comprehensive assessment.

Future Directions and Emerging Technologies

Artificial Intelligence and Machine Learning

AI-powered analysis of advanced monitoring data shows promise for:

Early sepsis detection
Fluid responsiveness prediction
Outcome prognostication
Personalized resuscitation protocols⁵⁰

Continuous Lactate Monitoring

Emerging biosensor technology enables real-time, continuous lactate monitoring without blood sampling⁵¹.

Wearable Microcirculatory Monitors

Development of wearable devices for continuous microcirculatory assessment may revolutionize bedside monitoring⁵².

Personalized Medicine Approaches

Genetic Factors in Lactate Metabolism

Understanding genetic variations in lactate metabolism may guide individualized resuscitation strategies⁵³.

Metabolomics and Advanced Biomarkers

Integration of metabolomic analysis with traditional monitoring parameters may provide deeper insights into cellular metabolism⁵⁴.

Point-of-Care Advances

Handheld Ultrasound Evolution

Next-generation handheld ultrasound devices with AI-powered analysis will further democratize POCUS capabilities⁵⁵.

Miniaturized Blood Analysis

Development of comprehensive point-of-care analyzers incorporating lactate, blood gases, and multiple biomarkers⁵⁶.

Practical Implementation Guidelines

Setting Up an Advanced Monitoring Program

Infrastructure Requirements

Point-of-care lactate analyzers
Continuous ScvO₂ monitoring capability
Portable ultrasound machines
Microcirculatory monitoring equipment (if available)
EMR integration capabilities

Training and Competency

Structured education programs for nursing and medical staff
Hands-on training with simulation-based learning
Competency assessment and maintenance protocols
Regular quality assurance and peer review⁵⁷

Quality Metrics and Outcome Measurement

Process Metrics

Time to lactate measurement in sepsis
Frequency of POCUS examinations
ScvO₂ monitoring compliance
Protocol adherence rates

Outcome Metrics

ICU length of stay
Mortality rates
Organ dysfunction scores
Patient safety indicators⁵⁸

Cost-Effectiveness Considerations

Economic Analysis

While advanced monitoring involves initial capital investment and ongoing costs, studies demonstrate cost-effectiveness through:

Reduced ICU length of stay
Decreased complications
Improved resource utilization
Better patient outcomes⁵⁹

Hack: Start with basic implementations (point-of-care lactate, basic POCUS) before investing in more advanced technologies. Focus on high-impact, low-cost interventions first.

Clinical Pearls and Oysters Summary

Top 10 Clinical Pearls

Lactate clearance >20% at 6 hours is more predictive of outcome than absolute values
ScvO₂ trends are more valuable than single measurements
IVC assessment in mechanically ventilated patients requires measuring distensibility, not collapsibility
B-lines on lung ultrasound >3 per space indicate interstitial syndrome
Microcirculatory dysfunction can persist despite hemodynamic optimization
Combination of parameters provides better assessment than single measurements
POCUS competency requires structured training and ongoing practice
Point-of-care lactate enables real-time clinical decision-making
NIRS vascular occlusion test provides functional microcirculatory assessment
Integration with EMR systems enables automated alerting and trend analysis

Key Oysters to Avoid

Don't chase lactate in liver disease patients - focus on trends
Normal ScvO₂ doesn't guarantee adequate tissue perfusion in sepsis
POCUS is operator-dependent - ensure adequate training and maintain competency
Don't assume normal macrocirculation equals normal microcirculation
Avoid over-reliance on single parameters - use multimodal assessment

Essential Hacks

Lactate + ScvO₂ combination: Low ScvO₂ + high lactate = inadequate delivery; High ScvO₂ + high lactate = impaired utilization
RUSH protocol for systematic shock evaluation: Heart, IVC, Aorta, Lungs
EMR automated alerts: Set up for lactate >4 mmol/L, ScvO₂ <65% or >80%
5-minute cardiac POCUS: Use standardized 5-view examination
Microcirculatory bedside assessment: Start with capillary refill and skin temperature gradient

Conclusion

Advanced ICU monitoring beyond traditional vital signs represents a paradigm shift in critical care practice. The integration of lactate assessment, ScvO₂ monitoring, POCUS evaluation, and microcirculatory assessment provides unprecedented insight into the pathophysiology of critical illness and enables targeted therapeutic interventions.

Success in implementing these advanced monitoring techniques requires systematic approach, adequate training, and integration with clinical protocols and decision-making processes. While technology continues to evolve, the fundamental principle remains unchanged: understanding the physiology behind the numbers and using this knowledge to optimize patient care.

The future of critical care monitoring lies in the seamless integration of multiple modalities, supported by artificial intelligence and personalized medicine approaches. As we advance into this new era, the focus must remain on translating technological capabilities into improved patient outcomes while maintaining cost-effectiveness and practical applicability.

For postgraduate trainees in critical care, mastery of these advanced monitoring techniques is essential for providing optimal patient care in the modern ICU. The journey from basic vital signs to comprehensive physiological assessment represents not just technological advancement, but a fundamental evolution in our understanding of critical illness and our ability to intervene effectively.

References

Vincent JL, Pelosi P, Pearse R, et al. Perioperative cardiovascular monitoring of high-risk patients: a consensus of 12. Crit Care. 2015;19:224.
Cecconi M, De Backer D, Antonelli M, et al. Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med. 2014;40(12):1795-1815.
Bakker J, Nijsten MW, Jansen TC. Clinical use of lactate monitoring in critically ill patients. Ann Intensive Care. 2013;3:12.
Garcia-Alvarez M, Marik P, Bellomo R. Sepsis-associated hyperlactatemia. Crit Care. 2014;18:503.
Jansen TC, van Bommel J, Schoonderbeek FJ, et al. Early lactate-guided therapy in intensive care unit patients: a multicenter, open-label, randomized controlled trial. Am J Respir Crit Care Med. 2010;182(6):752-761.
Levy B, Gibot S, Franck P, et al. Relation between muscle Na+K+ ATPase activity and raised lactate concentrations in septic shock: a prospective study. Lancet. 2005;365:871-875.
Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med. 2017;43(3):304-377.
Nguyen HB, Rivers EP, Knoblich BP, et al. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med. 2004;32(8):1637-1642.
Marty P, Roquilly A, Vallée F, et al. Lactate clearance for death prediction in severe sepsis or septic shock patients during the first 24 hours in Intensive Care Unit: an observational study. Ann Intensive Care. 2013;3:3.
Hajjar LA, Almeida JP, Fukushima JT, et al. High lactate levels are predictors of major complications after cardiac surgery. J Thorac Cardiovasc Surg. 2013;146(2):455-460.
Bellomo R, Kellum JA, Gandhi CR, et al. The rationale for continuous renal replacement therapy in sepsis and related syndromes. Contrib Nephrol. 2001;132:303-315.
Kraut JA, Madias NE. Lactic acidosis. N Engl J Med. 2014;371:2309-2319.
Fall PJ, Szerlip HM. Lactic acidosis: from sour milk to septic shock. J Intensive Care Med. 2005;20:255-271.
Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345(19):1368-1377.
Collaborative Study Group on Perioperative ScvO2 Monitoring. Multicentre study on peri- and postoperative central venous oxygen saturation in high-risk surgical patients. Crit Care. 2006;10:R158.
ARISE Investigators; ANZICS Clinical Trials Group. Goal-directed resuscitation for patients with early septic shock. N Engl J Med. 2014;371(16):1496-1506.
ProCESS Investigators. A randomized trial of protocol-based care for early septic shock. N Engl J Med. 2014;370(18):1683-1693.
Pölönen P, Ruokonen E, Hippeläinen M, et al. A prospective, randomized study of goal-oriented hemodynamic therapy in cardiac surgical patients. Anesth Analg. 2000;90(5):1052-1059.
Reinhart K, Kuhn HJ, Hartog C, Bredle DL. Continuous central venous and pulmonary artery oxygen saturation monitoring in the critically ill. Intensive Care Med. 2004;30(8):1572-1578.
Textoris J, Fouché L, Wiramus S, et al. High central venous oxygen saturation in the latter stages of septic shock is associated with increased mortality. Crit Care. 2011;15(4):R176.
Mayo PH, Beaulieu Y, Doelken P, et al. American College of Chest Physicians/La Société de Réanimation de Langue Française statement on competence in critical care ultrasonography. Chest. 2009;135(4):1050-1060.
Levitov A, Frankel HL, Blaivas M, et al. Guidelines for the appropriate use of bedside general and cardiac ultrasonography in the evaluation of critically ill patients-part II: cardiac ultrasonography. Crit Care Med. 2016;44(6):1206-1227.
Via G, Hussain A, Wells M, et al. International evidence-based recommendations for focused cardiac ultrasound. J Am Soc Echocardiogr. 2014;27(7):683.e1-683.e33.
Rudski LG, Lai WW, Afilalo J, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography. J Am Soc Echocardiogr. 2010;23(7):685-713.
Volpicelli G, Elbarbary M, Blaivas M, et al. International evidence-based recommendations for point-of-care lung ultrasound. Intensive Care Med. 2012;38(4):577-591.
Lichtenstein DA, Mezière GA. Relevance of lung ultrasound in the diagnosis of acute respiratory failure: the BLUE protocol. Chest. 2008;134(1):117-125.
Lichtenstein DA. FALLS-protocol: lung ultrasound in hemodynamic assessment of shock. Heart Lung Vessel. 2013;5(3):142-147.
Robba C, Santori G, Czosnyka M, et al. Optic nerve sheath diameter measured sonographically as non-invasive estimator of intracranial pressure: a systematic review and meta-analysis. Intensive Care Med. 2018;44(8):1284-1294.
Perlas A, Davis L, Khan M, et al. Gastric sonography in the fasted surgical patient: a prospective descriptive study. Anesth Analg. 2011;113(1):93-97.
Expert Round Table on Ultrasound in ICU. International expert statement on training standards for critical care ultrasonography. Intensive Care Med. 2011;37(7):1077-1083.
De Backer D, Hollenberg S, Boerma C, et al. How to evaluate the microcirculation: report of a round table conference. Crit Care. 2007;11:R101.
Ince C. Hemodynamic coherence and the rationale for monitoring the microcirculation. Crit Care. 2015;19 Suppl 3:S8.
Boerma EC, Mathura KR, van der Voort PH, et al. Quantifying bedside-derived imaging of microcirculatory abnormalities in septic patients: a prospective validation study. Crit Care. 2005;9:R601-R606.
Gómez H, Torres A, Polanco P, et al. Use of non-invasive NIRS during a vascular occlusion test to assess dynamic tissue O₂ saturation response. Intensive Care Med. 2008;34(9):1600-1607.
Creteur J, Carollo T, Soldati G, et al. The prognostic value of muscle StO2 in septic patients. Intensive Care Med. 2007;33(9):1549-1556.
Lima A, Bakker J. Clinical assessment of peripheral circulation. Curr Opin Crit Care. 2015;21(3):226-231.
De Backer D, Creteur J, Preiser JC, et al. Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med. 2002;166(1):98-104.
Sakr Y, Dubois MJ, De Backer D, et al. Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med. 2004;32(9):1825-1831.
Trzeciak S, Dellinger RP, Parrillo JE, et al. Early microcirculatory perfusion derangements in patients with severe sepsis and septic shock: relationship to hemodynamics, oxygen transport, and survival. Ann Emerg Med. 2007;49(1):88-98.
Creteur J, De Backer D, Sakr Y, et al. Sublingual capnometry tracks microcirculatory changes in septic patients. Intensive Care Med. 2006;32(4):516-523.
den Uil CA, Klijn E, Lagrand WK, et al. The microcirculation in health and critical disease. Prog Cardiovasc Dis. 2008;51(2):161-170.
Briers D, Duncan DD, Hirst E, et al. Laser speckle contrast imaging: theoretical and practical limitations. J Biomed Opt. 2013;18(6):066018.
Allen J. Photoplethysmography and its application in clinical physiological measurement. Physiol Meas. 2007;28(3):R1-39.
Spronk PE, Ince C, Gardien MJ, et al. Nitroglycerin in septic shock after intravascular volume resuscitation. Lancet. 2002;360(9343):1395-1396.
Vincent JL, Rhodes A, Perel A, et al. Clinical review: Update on hemodynamic monitoring--a consensus of 16. Crit Care. 2011;15(4):229.
Levy MM, Evans LE, Rhodes A. The Surviving Sepsis Campaign Bundle: 2018 update. Intensive Care Med. 2018;44(6):925-928.
Pearse RM, Harrison DA, MacDonald N, et al. Effect of a perioperative, cardiac output-guided hemodynamic therapy algorithm on outcomes following major gastrointestinal surgery: a randomized clinical trial and systematic review. JAMA. 2014;311(21):2181-2190.
Saugel B, Vincent JL, Wagner JY. Personalized hemodynamic management. Curr Opin Crit Care. 2017;23(4):334-341.
Moorman JR, Carlo WA, Kattwinkel J, et al. Mortality reduction by heart rate characteristic monitoring in very low birth weight neonates: a randomized trial. J Pediatr. 2011;159(6):900-906.
Rajkomar A, Dean J, Kohane I. Machine learning in medicine. N Engl J Med. 2019;380(14):1347-1358.
Pfützner A, Mitri M, Musholt PB, et al. Clinical assessment of a continuous glucose monitoring device (TensorTip MTX) under conditions similar to daily life. Diabetes Technol Ther. 2004;6(3):378-386.
Amelard R, Hughson RL, Greaves DK, et al. Non-contact hemodynamic imaging reveals the jugular venous pulse waveform. Sci Rep. 2017;7:40150.
Galley HF. Oxidative stress and mitochondrial dysfunction in sepsis. Br J Anaesth. 2011;107(1):57-64.
Seymour CW, Yende S, Scott MJ, et al. Metabolomics in pneumonia and sepsis: an analysis of the GenIMS cohort study. Intensive Care Med. 2013;39(8):1423-1434.
Butterfly Network Inc. Butterfly iQ+ Ultrasound System. FDA 510(k) clearance K193251. 2020.
Nichols JH, Christenson RH, Clarke W, et al. Executive summary. The National Academy of Clinical Biochemistry Laboratory Medicine Practice Guideline: evidence-based practice for point-of-care testing. Clin Chim Acta. 2007;379(1-2):14-28.
Frankel HL, Kirkpatrick AW, Elbarbary M, et al. Guidelines for the appropriate use of bedside general and cardiac ultrasonography in the evaluation of critically ill patients-Part I: General ultrasonography. Crit Care Med. 2015;43(11):2479-2502.
Pronovost PJ, Berenholtz SM, Needham DM. Translating evidence into practice: a model for large scale knowledge translation. BMJ. 2008;337:a1714.
Kochanek KD, Murphy SL, Xu J, Arias E. Deaths: Final Data for 2017. National Vital Statistics Reports. 2019;68(9):1-77.
Sessler CN, Shepherd W. New concepts in sepsis. Curr Opin Crit Care. 2002;8(6):465-472.

Abbreviations

ARDS: Acute Respiratory Distress Syndrome
CO: Cardiac Output
CVP: Central Venous Pressure
DO₂: Oxygen Delivery
EGDT: Early Goal-Directed Therapy
EMR: Electronic Medical Record
FICE: Focused Intensive Care Echocardiography
Hb: Hemoglobin
ICP: Intracranial Pressure
IDF: Incident Dark-Field
IVC: Inferior Vena Cava
LSCI: Laser Speckle Contrast Imaging
NIRS: Near-Infrared Spectroscopy
ONSD: Optic Nerve Sheath Diameter
POCUS: Point-of-Care Ultrasound
SaO₂: Arterial Oxygen Saturation
ScvO₂: Central Venous Oxygen Saturation
SDF: Sidestream Dark-Field
StO₂: Tissue Oxygen Saturation
SvO₂: Mixed Venous Oxygen Saturation
VO₂: Oxygen Consumption
VOT: Vascular Occlusion Test

Conflicts of Interest: The authors declare no conflicts of interest relevant to this article.

Funding: No specific funding was received for this work.

Wednesday, September 17, 2025